Medifast Stock News

BALTIMORE , April 18, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA ® , will announce financial resu

Medifast operates with a high growth business model with recurring revenue.

Dividends are a powerful tool that investors should employ to achieve a balance of total return and low volatility.

Medifast (MED) has been seeing high SG&A expenses for a while now, mainly due to higher OPTAVIA commission costs. The company's gross margin has also been under pressure.

MEDIFAST INC with ticker code (MED) now have 3 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 350 and 345 and has a mean target at 348. Now with the previous closing price of 179.64 this would indicate that there is a potential upside of 93.7%. The 50 day moving average now sits at 195.19 and the 200 day MA is 228.26. The market capitalisation for the company is $2,119m. Visit the company website at: https://medifastinc.com [stock_market_widget type="chart" template="basic" color="green" assets=MED" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,105m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands.

By the end of 2021, Medifast's revenue grew by 63.2%, and the number of coaches grew by 35.3% year-over-year to 59.8 thousand.

Medifast and La-Z-Boy are among a group of struggling small-cap stocks that appear to have the wherewithal to keep paying dividends.

Medifast's (MED) CEO Dan Chard on Q4 2021 Results - Earnings Call Transcript

Medifast press release (MED): GAAP EPS of $2.91 beats by $0.26.Revenue of $377.8M (+42.6% Y/Y) beats by $2.01M.Outlook: The company expects full-year 2022 revenue to be in the range…

BALTIMORE, Feb. 23, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 Highlights Compared…

Medifast (MED) delivered earnings and revenue surprises of 8.99% and 0.49%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Medifast (NYSE:MED) is scheduled to announce Q4 earnings results on Wednesday, February 23rd, after market close.The consensus EPS Estimate is $2.65 and the consensus Revenue Estimate

Medifast's (MED) fourth-quarter 2021 results are likely to reflect strength in the OPTAVIA lifestyle solution and coaching support system and the benefits from growth-related initiatives.

MEDIFAST INC with ticker code (MED) now have 3 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 350 and 345 with a mean TP of 348. With the stocks previous close at 190.8 this would imply there is a potential upside of 82.4%. The day 50 moving average is 201.46 and the 200 moving average now moves to 235.64. The company has a market cap of $2,222m. Find out more information at: https://medifastinc.com [stock_market_widget type="chart" symbol="MED" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $4,052m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands.

Stocks with rising P/E often proves to be an intriguing investing idea.